Relevant Data

Food Additives Approved in the United States:

Food Additives Approved by WHO:


General Information

Chemical name3-Methyl-2-oxobutyric acid
CAS number759-05-7
COE number2262
JECFA number631
Flavouring typesubstances
FL No.08.051
MixtureNo
Purity of the named substance at least 95% unless otherwise specified
Reference bodyJECFA

From webgate.ec.europa.eu

Computed Descriptors

Download SDF
2D Structure
CID49
IUPAC Name3-methyl-2-oxobutanoic acid
InChIInChI=1S/C5H8O3/c1-3(2)4(6)5(7)8/h3H,1-2H3,(H,7,8)
InChI KeyQHKABHOOEWYVLI-UHFFFAOYSA-N
Canonical SMILESCC(C)C(=O)C(=O)O
Molecular FormulaC5H8O3
Wikipedia3-methyl-2-oxobutanoate

From Pubchem


Computed Properties

Property Name Property Value
Molecular Weight116.116
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count2
Complexity115.0
CACTVS Substructure Key Fingerprint A A A D c c B g M A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g A A C A A A D Q S A g A A C C A A A A g A I A I C Q C A I A A A A A A A A A A A F A A A A A A B A A A A A A Q A A E A A A A A A A A A A A I A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = =
Topological Polar Surface Area54.4
Monoisotopic Mass116.047
Exact Mass116.047
XLogP3None
XLogP3-AA0.7
Compound Is CanonicalizedTrue
Formal Charge0
Heavy Atom Count8
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Isotope Atom Count0
Covalently-Bonded Unit Count1

From Pubchem


Food Additives Biosynthesis/Degradation


ADMET Predicted Profile --- Classification

Model Result Probability
Absorption
Blood-Brain BarrierBBB+0.9371
Human Intestinal AbsorptionHIA+0.9764
Caco-2 PermeabilityCaco2-0.6143
P-glycoprotein SubstrateNon-substrate0.7906
P-glycoprotein InhibitorNon-inhibitor0.9239
Non-inhibitor0.9466
Renal Organic Cation TransporterNon-inhibitor0.9548
Distribution
Subcellular localizationMitochondria0.8824
Metabolism
CYP450 2C9 SubstrateNon-substrate0.8246
CYP450 2D6 SubstrateNon-substrate0.9285
CYP450 3A4 SubstrateNon-substrate0.7040
CYP450 1A2 InhibitorNon-inhibitor0.9811
CYP450 2C9 InhibitorNon-inhibitor0.9109
CYP450 2D6 InhibitorNon-inhibitor0.9584
CYP450 2C19 InhibitorNon-inhibitor0.9804
CYP450 3A4 InhibitorNon-inhibitor0.9813
CYP Inhibitory PromiscuityLow CYP Inhibitory Promiscuity0.9905
Excretion
Toxicity
Human Ether-a-go-go-Related Gene InhibitionWeak inhibitor0.9939
Non-inhibitor0.9736
AMES ToxicityNon AMES toxic0.9163
CarcinogensCarcinogens 0.5840
Fish ToxicityHigh FHMT0.5152
Tetrahymena Pyriformis ToxicityLow TPT0.9597
Honey Bee ToxicityHigh HBT0.7319
BiodegradationReady biodegradable0.8850
Acute Oral ToxicityIII0.6948
Carcinogenicity (Three-class)Non-required0.8040

From admetSAR


ADMET Predicted Profile --- Regression

Model Value Unit
Absorption
Aqueous solubility-0.0172LogS
Caco-2 Permeability0.6555LogPapp, cm/s
Distribution
Metabolism
Excretion
Toxicity
Rat Acute Toxicity1.5628LD50, mol/kg
Fish Toxicity3.2248pLC50, mg/L
Tetrahymena Pyriformis Toxicity-0.8584pIGC50, ug/L

From admetSAR


Toxicity Profile

Route of ExposureNone
Mechanism of ToxicityNone
MetabolismNone
Toxicity ValuesNone
Lethal DoseNone
Carcinogenicity (IARC Classification)No indication of carcinogenicity to humans (not listed by IARC).
Minimum Risk LevelNone
Health EffectsChronically high levels of alpha-ketoisovaleric acid are associated with Maple Syrup Urine Disease.
TreatmentNone
Reference
  1. Shoemaker JD, Elliott WH: Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease. J Chromatogr. 1991 Jan 2;562(1-2):125-38.[2026685 ]
  2. Lee SH, Kim SO, Chung BC: Gas chromatographic-mass spectrometric determination of urinary oxoacids using O-(2,3,4,5,6-pentafluorobenzyl)oxime-trimethylsilyl ester derivatization and cation-exchange chromatography. J Chromatogr B Biomed Sci Appl. 1998 Nov 20;719(1-2):1-7.[9869358 ]
  3. Tsuchiya H, Hashizume I, Tokunaga T, Tatsumi M, Takagi N, Hayashi T: High-performance liquid chromatography of alpha-keto acids in human saliva. Arch Oral Biol. 1983;28(11):989-92.[6581765 ]
  4. Schaefer K, von Herrath D, Erley CM, Asmus G: Calcium ketovaline as new therapy for uremic hyperphosphatemia. Miner Electrolyte Metab. 1990;16(6):362-4.[2089249 ]
  5. Livesey G, Lund P: Binding of branched-chain 2-oxo acids to bovine serum albumin. Biochem J. 1982 Apr 15;204(1):265-72.[7115325 ]
  6. Shigematsu Y, Kikuchi K, Momoi T, Sudo M, Kikawa Y, Nosaka K, Kuriyama M, Haruki S, Sanada K, Hamano N, et al.: Organic acids and branched-chain amino acids in body fluids before and after multiple exchange transfusions in maple syrup urine disease. J Inherit Metab Dis. 1983;6(4):183-9.[6422161 ]
  7. Chuang DT, Niu WL, Cox RP: Activities of branched-chain 2-oxo acid dehydrogenase and its components in skin fibroblasts from normal and classical-maple-syrup-urine-disease subjects. Biochem J. 1981 Oct 15;200(1):59-67.[6895847 ]
  8. Gallina DL, Dominguez JM, Hoschoian JC, Barrio JR: Maintenance of nitrogen balance in a young woman by substitution of -ketoisovaleric acid for valine. J Nutr. 1971 Sep;101(9):1165-7.[5096137 ]
  9. Schauder P, Schroder K, Langenbeck U: Serum branched-chain amino and keto acid response to a protein-rich meal in man. Ann Nutr Metab. 1984;28(6):350-6.[6393856 ]

From T3DB


Taxonomic Classification

KingdomOrganic compounds
SuperclassOrganic acids and derivatives
ClassKeto acids and derivatives
SubclassShort-chain keto acids and derivatives
Intermediate Tree NodesNot available
Direct ParentShort-chain keto acids and derivatives
Alternative Parents
Molecular FrameworkAliphatic acyclic compounds
SubstituentsBranched fatty acid - Methyl-branched fatty acid - Short-chain keto acid - Alpha-keto acid - Fatty acyl - Alpha-hydroxy ketone - Ketone - Carboxylic acid derivative - Carboxylic acid - Monocarboxylic acid or derivatives - Carbonyl group - Hydrocarbon derivative - Organic oxygen compound - Organooxygen compound - Organic oxide - Aliphatic acyclic compound
DescriptionThis compound belongs to the class of organic compounds known as short-chain keto acids and derivatives. These are keto acids with an alkyl chain the contains less than 6 carbon atoms.

From ClassyFire


Targets

General Function:
L-valine transaminase activity
Specific Function:
Catalyzes the first reaction in the catabolism of the essential branched chain amino acids leucine, isoleucine, and valine. May also function as a transporter of branched chain alpha-keto acids.
Gene Name:
BCAT2
Uniprot ID:
O15382
Molecular Weight:
44287.445 Da
References
  1. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [17016423 ]
General Function:
Metal ion binding
Specific Function:
Catalyzes the reversible reaction in which hydroxymethyl group from 5,10-methylenetetrahydrofolate is tranferred onto alpha-ketoisovalerate to form ketopantoate.
Gene Name:
panB
Uniprot ID:
Q9JZW6
Molecular Weight:
27739.07 Da
General Function:
L-ascorbic acid binding
Specific Function:
Catalyzes the step from penicillin N to deacetoxy-cephalosporin C.
Gene Name:
cefE
Uniprot ID:
P18548
Molecular Weight:
34555.38 Da
General Function:
Catalyzes the condensation of the acetyl group of acetyl-CoA with 3-methyl-2-oxobutanoate (2-oxoisovalerate) to form 3-carboxy-3-hydroxy-4-methylpentanoate (2-isopropylmalate).
Specific Function:
2-isopropylmalate synthase activity
Gene Name:
leuA
Uniprot ID:
P9WQB3
Molecular Weight:
70112.945 Da

From T3DB